Mid Day Update
By Brett Goldstein on May 04, 2007
9 Responses to “Mid Day Update”
Hey Blain. There is no chart for IBKR yet. It just started trading like 3 hours ago. I wasent able to sell my DNDN call for the price i wanted to so Im just gonna wait it out I guess. Good Luck and great site again.
I was able to get IBKR pre IPO… dropped my shares at 33 though because I expected a higher pop to begin with.
IBKR looks good, Sharebuilder released conditional offers @ around $27 per (75% sure). IPO came at top end of expectations, waiting to see a fall closer towards the low end before I jump in.
Check out my thoughts here:
http://www.wallstreetmatador.com/stock-charts/ibkrs-ipo-results/
WSM
JST is taking a beating. Earnings are always very volatile. I picked some more up though and just put a stop loss at 17.90. We`ll see how that works.
true, if i had known earnings was coming up i woudl have locked in some gains
oh well
Leave a Comment
Recent Blog Posts
- RGR (Sturm Ruger) Stock Chart Update
- Cree (Cree) Stock Chart
- RGR (Strum Ruger) Stock Chart
- Mako (MAKO Surgical Corp) Stock Chart
- Mako (MAKO Surgical Corp) Stock Chart
- Cree (Cree) Stock Chart
- Cree (Cree) Stock Chart
- Out of ACTG - Quick 7 points. How much did you make??
- Out of Mako.....Shorted ACTG
- Shorted Mako at $38.50
- Some stock charts I am looking at
- PEET (Peets coffee and tea) Stock Chart
- EXPE (Expedia Stock Chart) Watch / Pick
- NATR (Natures Sunshine Products) Stock Chart Watch
- Cree (Cree Inc) Stock Chart Watch
- Picks Vs. Watches
- BiiB (Biogen) Stock Chart
- Vera Bradley
- Tradeable Themes
- GLUU
- Stock Charts $5..Send stocks to BrettG83@gmail.com
- VG (Vonage) Stock Chart
- 30 points in 10 days (LNKD)
- DRC (Dresser-Rand Group Inc) Stock Chart
- Who wants to get Linked In?
- Cat (Caterpiller) Chart
- Did anyone get in this stock.....15 pts ago????
- Crox (Crocs) Stock Chart
- SBR (Sabine Royalty Trust) Ascending Triangle
- A few good points.





is is IBKR pink sheet or something? not pulling up on my charting service, hmm…
DNDN is going to continue to be horribly volatile on both side of the equation, I believe it is the 15th FDA is supposed to make an announcement on their drug. Hopefully phase III trials are good.